Long-Term Outcomes and Patency of Left Carotid-Subclavian Bypass in Thoracic Endovascular Aortic Repair
European Journal of Cardio-Thoracic Surgery · 2025
DOI: 10.1093/ejcts/ezaf391 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cardio-Thoracic Surgery, 2025. Verfasst von Giacomo Murana und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiac Surgery, Cardiac Surgery Department, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, Bologna, 40138, Italy. Hauptthemen laut MEDLINE: Endovascular Procedures, Subclavian Artery, Aorta, Thoracic, Vascular Patency. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Objectives
Left carotid-subclavian bypass (LCSB) is a classic strategy for left subclavian artery (LSA) revascularization in thoracic endovascular aortic repair (TEVAR) patients. Its employment has been reduced in recent years due to the advent of endovascular solutions for LSA management. Data on outcomes of LCSB are lacking, especially for graft-related complications and patency at follow-up.
Methods
All patients who underwent TEVAR with LCSB from November 2005 to January 2025, in an elective or urgent setting, were retrospectively analysed in terms of pre- and intraoperative characteristics, short- and mid-term outcomes. In-hospital outcomes were compared between the urgent and elective groups. LCSB patency at follow-up imaging was reported. A Kaplan-Meier analysis was performed on survival, freedom from reintervention and LCSB patency.
Results
LCSB was performed in 161 patients, 36 of which (22.3%) were urgent procedures. In-hospital mortality was 3.7%, with no significant difference between the elective and the urgent group (3.2% vs 5.6% respectively, P = .491). There was a not statistically significantly higher incidence of stroke in the urgent patients (0.8% vs 5.6%, P = .057). LCSB-related complications occurred in 12 patients (7.4%). Overall LCSB patency at last available follow-up was 97.4%. LSA embolization was necessary in 7 cases (4.5%) due to type II endoleak. At 5 years, survival was 87.4%, freedom from reintervention was 88.5% and LCSB patency was 99%.
Conclusions
LCSB is safe and effective as a LSA revascularization strategy. Even in urgent patients, LCSB was not linked to worse in-hospital outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiac Surgery, Cardiac Surgery Department, IRCCS, Azienda Ospedaliero-Universitaria di Bologna, Bologna, 40138, Italy.
- Department of Medical and Surgical Sciences, DIMEC, Alma Mater Studiorum-University of Bologna, Bologna, 40138, Italy.
- Pediatric and Adult CardioThoracic and Vascular, Oncohematologic and Emergency Radiology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, 40138, Italy.
ORCID-Profile: Giacomo Murana, Giulio Giovanni Cavalli, Davide Pacini
Zitieren
APA
Murana, G., Nocera, C., Di Marco, L., Buia, F., Garofalo, R., Aksit, G., Cavalli, G. G., & Pacini, D. (2025). Long-Term Outcomes and Patency of Left Carotid-Subclavian Bypass in Thoracic Endovascular Aortic Repair. European Journal of Cardio-Thoracic Surgery. https://doi.org/10.1093/ejcts/ezaf391
Vancouver
Murana G, Nocera C, Di Marco L, Buia F, Garofalo R, Aksit G, et al. Long-Term Outcomes and Patency of Left Carotid-Subclavian Bypass in Thoracic Endovascular Aortic Repair. European Journal of Cardio-Thoracic Surgery. 2025. doi:10.1093/ejcts/ezaf391
BibTeX
@article{Murana2025,
author = {Murana, Giacomo and Nocera, Chiara and Di Marco, Luca and Buia, Francesco and Garofalo, Riccardo and Aksit, Gokdeniz and Cavalli, Giulio Giovanni and Pacini, Davide},
title = {Long-Term Outcomes and Patency of Left Carotid-Subclavian Bypass in Thoracic Endovascular Aortic Repair},
journal = {European Journal of Cardio-Thoracic Surgery},
year = {2025},
doi = {10.1093/ejcts/ezaf391}
}
EUVIMED